Pets at Home Group Plc PAHGF OTC · Consumer cyclical · United Kingdom
$2.72 +0.00% +$0.00
Summary
56 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has raised its dividend 5 years in a row and pays out only 37% of profit.
- It bought back its own shares for £30.5M in the last fiscal year, 3.5% of its market value.
What to watch
- Earnings per share fell by 13% a year over the last 3 years.
- Out of every 100 GBP of revenue, only 4.3 GBP is left as net profit.
- It earns only 4.8 GBP a year on every 100 GBP of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.0 GBP for 1 GBP of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (GBP)
Diluted EPS (GBP)
- Analyst estimate
Revenue grew by 5.2% a year over 5 years. Over the last 3 years it grew by 1.6% a year. For the next fiscal year analysts expect revenue to grow by 3.4%. Earnings per share fell by 13% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 GBP of revenue goes
- Cost of sales 54 GBP
- Sales and administration 39 GBP
- Taxes and other 2.0 GBP
- Net profit 4.3 GBP
Net profit, industry median (Specialty Retail) 4.0 GBP
Out of every 100 GBP of revenue, 4.3 GBP is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 2.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 2.65%
- Paid out of profit
- 37%
- Raised in a row
- 5 years
You receive $0.07 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.